Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors (Q33387877)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q107069384)
(Q96244689)
(P304) 473-480
(P407) (Q1860)
(P433) 3
(P478) 29
(P577) Friday, January 15, 2010
(P921) (Q412415)
(P1433) (Q2312231)
(P1476) "Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors" (language: en)
(P2093) David O Toft
Rui Qin
Bridget A Stensgard
Sara Felten
Cynthia Ten Eyck
Gretchen Batzel
S Percy Ivy
Paul Haluska
(P2860) (Q34898930)
(Q37718291)
(Q36948038)
(Q37226339)
(Q33377626)
(Q35469572)
(Q33374574)
(Q40624388)
(Q35551875)
(Q34217071)
(Q29620335)
(Q39698998)
(Q40778294)
(Q29617837)
(Q34319594)
(Q28131713)
(Q33824746)
(Q42492406)
(Q28368209)
(Q42826312)
(Q28248831)
(Q24627720)
(Q24564127)
(Q34720809)
(Q48474924)
(Q46481184)
(Q81414742)
(Q79297587)
other details